Cellatope Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$5M
Cellatope General Information
Description
Developer of inflammatory diseases identification and monitoring solutions. The company helps user to analyze complement products bound to various blood cell types such as erythrocytes, platelets, reticulocytes, and lymphocytes.
Contact Information
Corporate Office
- 100 Technology Drive
- Suite 400
- Pittsburgh, PA 15219
- United States
Corporate Office
- 100 Technology Drive
- Suite 400
- Pittsburgh, PA 15219
- United States
Cellatope Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 01-Feb-2009 | $5M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series B) | 02-Apr-2007 | Completed | Startup | |||
| 1. Early Stage VC (Series A) | 02-Oct-2005 | $638K | $638K | Completed | Startup |
Cellatope Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Cellatope Patents
Cellatope Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2009042423-A1 | Methods and compositions for improved diagnostic assays | Inactive | 27-Sep-2007 |
Cellatope Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioAdvance Capital (Conshohocken) | Venture Capital | Minority | ||
| BlueTree Allied Angels | Angel Group | Minority | ||
| Innovation Works | Venture Capital | Minority | ||
| Meyer and Co. | Merchant Banking Firm | Minority | ||
| Pittsburgh Life Sciences Greenhouse | Venture Capital | Minority |
Cellatope FAQs
-
When was Cellatope founded?
Cellatope was founded in 2004.
-
Where is Cellatope headquartered?
Cellatope is headquartered in Pittsburgh, PA.
-
What industry is Cellatope in?
Cellatope’s primary industry is Diagnostic Equipment.
-
Is Cellatope a private or public company?
Cellatope is a Private company.
-
What is the current valuation of Cellatope?
The current valuation of Cellatope is .
-
What is Cellatope’s current revenue?
The current revenue for Cellatope is .
-
How much funding has Cellatope raised over time?
Cellatope has raised $2M.
-
Who are Cellatope’s investors?
BioAdvance Capital (Conshohocken), BlueTree Allied Angels, Innovation Works, Meyer and Co., and Pittsburgh Life Sciences Greenhouse are 5 of 7 investors who have invested in Cellatope.
-
When was Cellatope acquired?
Cellatope was acquired on 01-Feb-2009.
-
Who acquired Cellatope?
Cellatope was acquired by Cypress Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process